The Scientist

» biotechnology and ecology

Most Recent

image: Biotech Stocks Take a Hit

Biotech Stocks Take a Hit

By | September 30, 2015

Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.

1 Comment

image: CRISPR 2.0?

CRISPR 2.0?

By | September 28, 2015

A pioneer of the gene-editing technique discovers a protein that could improve its accuracy.

0 Comments

image: Direct-to-Consumer Liquid Biopsy

Direct-to-Consumer Liquid Biopsy

By | September 13, 2015

Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.

0 Comments

image: Characterizing DNA Quadruplexes

Characterizing DNA Quadruplexes

By | September 10, 2015

Researchers are developing new techniques to better understand how and why knots of DNA are distributed throughout the genome.

0 Comments

image: Citation Payola?

Citation Payola?

By | August 18, 2015

A transgenic mouse company is paying researchers who mention its animal models in scientific papers.

1 Comment

image: Butterflies in Peril

Butterflies in Peril

By | August 12, 2015

Several recent studies point to serious—and mysterious—declines in butterfly numbers across the globe.

5 Comments

image: FDA Approves 3-D–Printed Drug

FDA Approves 3-D–Printed Drug

By | August 4, 2015

The US Food and Drug Administration green lights the first medicine produced by a 3-D printer for use in the human body.

1 Comment

image: Mimicry Muses

Mimicry Muses

By | August 1, 2015

The animal world is full of clever solutions to bioengineering challenges.

0 Comments

image: RoboSpleen

RoboSpleen

By | August 1, 2015

Witness a bioinspired device developed by researchers at Harvard’s Wyss Institute to treat sepsis.

1 Comment

image: Inspired by Nature

Inspired by Nature

By | August 1, 2015

Researchers are borrowing designs from the natural world to advance biomedicine.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech